Relationship between linear and nonlinear dynamics of heart rate and impairment of lung function in COPD patients

International Journal of COPD

Volumn 10, Issue 1, 2015, Pages 1651-1661

  Mazzuco, Adriana ^a   Medeiros, Wladimir Musetti ^b   Sperling, Milena Pelosi Rizk ^a   de Souza, Aline Soares ^b   Alencar, Maria Clara Noman ^b   Arbex, Flávio Ferlin ^b   Neder, José Alberto ^b,c   Arena, Ross ^d   Borghi Silva, Audrey ^a  

^a FEDERAL UNIVERSITY OF SÃO CARLOS   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c QUEEN S UNIVERSITY   (Canada)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Cardiac autonomic nervous system; COPD; Heart rate variability; Lung diffusion capacity; Rest hyperinflation; Static lung volumes

Indexed keywords

AGED; BIOLOGICAL MODEL; BRAZIL; CHOLINERGIC SYSTEM; CROSS-SECTIONAL STUDY; HEART; HEART RATE; HUMAN; INNERVATION; LUNG; LUNG DIFFUSION CAPACITY; LUNG VOLUME; MALE; MIDDLE AGED; NONLINEAR SYSTEM; PATHOPHYSIOLOGY; PATIENT POSITIONING; PREDICTIVE VALUE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEDENTARY LIFESTYLE; SEVERITY OF ILLNESS INDEX; SPIROMETRY; STATISTICAL MODEL; SUPINE POSITION;

AGED; BRAZIL; CROSS-SECTIONAL STUDIES; HEART; HEART RATE; HUMANS; LINEAR MODELS; LUNG; LUNG VOLUME MEASUREMENTS; MALE; MIDDLE AGED; MODELS, CARDIOVASCULAR; NONLINEAR DYNAMICS; PARASYMPATHETIC NERVOUS SYSTEM; PATIENT POSITIONING; PREDICTIVE VALUE OF TESTS; PULMONARY DIFFUSING CAPACITY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEDENTARY LIFESTYLE; SEVERITY OF ILLNESS INDEX; SPIROMETRY; SUPINE POSITION;

EID: 84939812396     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S81736     Document Type: Article

References (48)

1. O’Donnell DE, Laveneziana P, Neder JA. Lung function. Eur Respir Monogr. 2013;62:127–145.
2. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. 2014. Available from: www.goldcopd.org. Accessed 15 October, 2014.
3. Jousilahti P, Vartiainen E, Tuomilehto J, Puska P. Symptoms of chronic bronchitis and the risk of coronary disease. Lancet. 1996;348:567–572.
4. Engström G, Wollmer P, Hedblad B, Juul-Möller S, Valind S, Janzon L.: Occurrence and prognostic significance of ventricular arrhythmia is related to pulmonary function. A study from “Men Born in 1914,” Malmö, Sweden. Circulation. 2001;103:3086–3091.
5. Anthonisen NR, Connett JE, Enright PL, Manfreda J; Lung Health Study Research Group. Hospitalizations and mortality in the Lung Health Study. Am J Respir Crit Care Med. 2002;166:333–339.
6. Sin DD, Wu LL, Paul Man SF. The relationship between reduced lung function and cardiovascular mortality. A population-based study and a systematic review of the literature. Chest. 2005;127:1952–1959.
7. Volterrani M, Scalvini S, Mazzuero G, et al. Decreased heart rate variability in patients with chronic obstructive pulmonary disease. Chest. 1994;106:1432–1437.
8. Pagani M, Lucini D, Pizzinelli P, Sergi M, Mela GS, Malliani A. Effects of aging and of chronic obstructive pulmonary disease on RR interval variability. J Auton Nerv Syst. 1996;59:125–132.
9. Reis MS, Arena R, Deus AP, Simões RP, Catai AM, Borghi-Silva A. Deep breathing heart rate variability is associated with respiratory muscle weakness in patients with chronic obstructive pulmonary disease. Clinics. 2010;65:396–375.
10. Reis MS, Deus AP, Simões RP, Aniceto IA, Catai AM, Borghi-Silva A. Autonomic control of heart rate in patients with chronic cardiorespiratory disease and in healthy participants at rest and during a respiratory sinus arrhythmia maneuver. Rev Bras Fisioter. 2010;14:106–113.
11. Seals DR, Suwarno NO, Dempsey JA. Influence of lung volume on sympathetic nerve discharge in normal humans. Circ Res. 1990;67:130–141.
12. Andreas S, Anker SD, Scanlon PD, Somers VK. Neurohumoral activation as a link to systemic manifestations of chronic lung disease. Chest. 2005;128:3618–3624.
13. Criée CP, Sorichter S, Smith HJ, et al. Body plethysmography and its principles and clinical use. Respir Med. 2011;105:959–971.
14. Casanova C, Cote C, Torres JP, et al. Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;171:591–597.
15. Zaman M, Mahmood S, Altayeh A. Low inspiratory capacity to total lung capacity ratio is a risk factor for chronic obstructive pulmonary disease exacerbation. Am J Med Sci. 2010;339:411–414.
16. Albuquerque AL, Nery LE, Villaça DS, et al. Inspiratory fraction and exercise impairment in COPD patients GOLD stages II–III. Eur Respir J. 2006;28:939–944.
17. Boutou AK, Shrikrishna D, Tanner RJ, et al. Lung function indices for predicting mortality in COPD. Eur Respir J. 2013;42:616–625.
18. Camillo CA, Pitta F, Possani HV, et al. Heart rate variability and disease characteristics in patients with COPD. Lung. 2008;186:393–401.
19. Corbo GM, Inchingolo R, Sgueglia GA, Lanza G, Valente S. C-reactive protein, lung hyperinflation and heart rate variability in chronic obstructive pulmonary disease – a pilot study. COPD. 2013;10:200–207.
20. Miller MR, Hankinson J, Brusasco V, et al. ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J. 2005;526:319–338.
21. Wanger J, Clausen JL, Coates A, et al. Standardisation of the measurement of lung volumes. Eur Respir J. 2005;26:511–522.
22. Macintyre N, Crapo RO, Viegi G, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J. 2005;26:720–735.
23. Barreto SS. [Lung volumes]. J Pneumol. 2002;28 Suppl 3:S83–S94. Portuguese.
24. Pereira CAC, Viegas CA, Alves RF. [Carbon monoxide diffusing capacity]. J Pneumol. 2002;28 Suppl 3:S122–S138. Portuguese.
25. Pereira CAC, Moreira MAF. [Plethysmography – airway resistance]. J Pneumol. 2002;28 Suppl 3:S139–S150. Portuguese.
26. Neder JA, Andreoni S, Lerario MC, Nery LE. Reference values for lung function tests: II. Maximal respiratory pressures and voluntary ventilation. Braz J Med Biol Res. 1999;32:719–727.
27. Williams AJ. Assessing and interpreting arterial blood gases and acidbase balance. BMJ. 1998;317:1213–1216.
28. Lang RM, Badano LP, Tsang W, et al. EAE/ASE recommendations for image acquisition and display using three-dimensional echocardiography. J Am Soc Echocardiogr. 2012;25:3–46.
29. Radespiel-Troger M, Rauh R, Mahlke C, Gottschalk T, Muck-Weymann M. Agreement of two different methods for measurement of heart rate variability. Clin Auton Res. 2003;13:99–102.
30. Camm A, Malik M, Bigger J, et al. Task Force of European Society of Cardiology and the North American Society of Pacing Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Circulation. 1996;93:1043–1065.
31. Ferreira MT. Caracterização do comportamento caótico da variabilidade da frequência cardíaca (VFC) em jovens saudáveis. [Characterization of heart rate variability (HRV) chaotic behavior in healthy young people]. TEMA Tend Mat Appl Comput. 2010;11:141–151. Portuguese.
32. Tarvainen MP, Niskanen JP, Lipponen JA, Ranta-Aho PO, Karjalainen PA. Kubios HRV – heart rate variability analysis software. Comput Method Prog Biomed. 2014;113:210–220.
33. Browner WS, Cummings SR, Hulley SB. [Estimating sample size and statistical power: key points]. In: Hulley SB, Cummings SR, Browner WS, Grady D, Hearst N, Newman TB, editors. [Designing Clinical Research: An Epidemiologic Approach]. 2nd ed. Porto Alegre, Brazil: Artmed; 2003. Portuguese.
34. Munro BH. Statistical Methods for Health Care Research. 4th ed. Philadelphia, PA, USA: JB Lippincott; 2000.
35. Soares-Miranda L, Sattelmair J, Chaves P, et al. Physical activity and heart rate variability in older adults – the Cardiovascular Health Study. Circulation. 2014;129:2100–2110.
36. Heindl S, Lehnert M, Criée C, Hasenfuss G, Andreas A. Marked sympathetic activation in patients with chronic respiratory failure. Am J Respir Crit Care Med. 2001;164:597–601.
37. Garcia-Araújo AS, Di Lorenzo VAP, Labadessa IG, et al. Increased sympathetic modulation and decreased response of the heart rate variability in controlled asthma. J Asthma. 2014;31:1–8.
38. Sin DD, Paul Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation. 2003;107:1514–1519.
39. Mäkikallio TH, Huikuri HV, Mäkikallio A, et al. Prediction of sudden cardiac death by fractal analysis of heart rate variability in elderly subjects. J Am Coll Cardiol. 2001;37:1395–1402.
40. Fishman M, Jacono FJ, Park S, et al. A method for analyzing temporal patterns of variability of a time series from Poincaré plots. J Appl Physiol. 2012;113:297–306.
41. Pikkujämsä SM, Mäkikallio TH, Sourander LB, et al. Cardiac interbeat interval dynamics from childhood to senescence. Comparison of conventional and new measures based on fractals and chaos theory. Circulation. 1999;100:393–399.
42. Algra A, Tijssen JG, Roelandt JR, Pool J, Lubsen J. Heart rate variability from 24-hour electrocardiography and the 2-year risk for sudden death. Circulation. 1993;88:180–185.
43. Malliani A, Pagani M, Lombardi F, Cerutti S. Cardiovascular neural regulation explored in the frequency domain. Circulation. 1991;84:482–492.
44. Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009;33:1165–1185.
45. Corsonello A, Incalzi RA, Pistelli R, Pedone C, Bustacchini S, Lattanzio F. Comorbidities of chronic obstructive pulmonary disease. Curr Opin Pulm Med. 2011;17 Suppl 1:S21–S28.
46. Cavaillès A, Brinchault-Rabin G, Dixmier A, et al. Comorbidities of COPD. Eur Respir Rev. 2013;22:454–475.
47. Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J. 2008;32:962–969.
48. Akselrod S, Gordon D, Ubel FA, Shannon DC, Berger AC, Cohen RJ. Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science. 1981;213:220–222.